Hôpital Avicenne
- Address
- lock Available on a paid plan
Hôpital Avicenne - Comprehensive Oncology and Hematology Research Center
Hôpital Avicenne is a distinguished medical research institution with extensive expertise in hematologic malignancies and solid tumor oncology. The center demonstrates particular strength in investigating advanced therapeutic strategies for complex blood disorders and cancer treatment, with a focus on targeted therapies, immunotherapy approaches, and treatment optimization for elderly populations.
- Acute and chronic myeloid leukemias, including FLT3-mutated AML and chronic myelogenous leukemia with novel combination therapies
- Advanced lung cancer and hepatocellular carcinoma utilizing immunotherapy and checkpoint inhibitors
- Hematologic disorders including polycythemia vera, B-cell malignancies, and myeloproliferative neoplasms
- Breast cancer and colorectal cancer research with emphasis on genomic profiling and adjuvant strategies in elderly patients
The center maintains active research programs in autoimmune diseases such as rheumatoid arthritis and primary biliary cholangitis, as well as HIV/AIDS treatment exploring novel antiretroviral combinations and broadly neutralizing antibodies. The institution's research portfolio reflects a commitment to addressing treatment gaps in difficult-to-treat patient populations, including those with relapsed/refractory disease states and elderly patients requiring specialized therapeutic approaches. Their involvement in international multicenter trials and adaptive trial designs demonstrates their leadership in advancing precision medicine and improving clinical outcomes across multiple therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 14 therapeutic areas and 15 of 108 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 104 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 20 by active trials.
- 1Centre Hospitalier De Versailles2active
lock +19 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB5trials
lock +9 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hôpital Avicenne
lock Showing 1 of 57 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 108 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azacitidine | 4 | Unknown | 2019-06-19 | 2026-03-02 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.